Arcus Biosciences, Inc. (NYSE:RCUS) showed up in the 13F filings of 202 institutional investors as of December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 31 Dec, 2025 | 0 | 3,187,025 | 26.98% | $0.00 |
| Gilead Sciences, Inc. | 31 Dec, 2025 | 0 | 0 | 0.00% | $0.00 |
| Woodline Partners LP | 31 Dec, 2025 | 0 | 104 | 0.00% | $0.00 |
| Barclays Plc | 31 Dec, 2025 | 0 | 816,485 | 276.05% | $0.00 |
| VANGUARD GROUP INC | 31 Dec, 2025 | 0 | 1,333,421 | 20.11% | $0.00 |
| Point72 Asset Management, L.P. | 31 Dec, 2025 | 0 | -1,052,479 | -24.29% | $0.00 |
| Rockefeller Capital Management L.P. | 31 Dec, 2025 | 0 | 20,592 | 534.02% | $0.00 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 0 | 1,500,000 | 40.66% | $0.00 |
| Siren, L.L.C. | 31 Dec, 2025 | 0 | 95,000 | 3.26% | $0.00 |
| WELLINGTON MANAGEMENT GROUP LLP | 31 Dec, 2025 | 0 | 3,918,220 | 309.43% | $0.00 |
| Sofinnova Investments, Inc. | 31 Dec, 2025 | 0 | -125,558 | -10.27% | $0.00 |
| State Street Corp | 31 Dec, 2025 | 0 | 1,182,115 | 34.82% | $0.00 |
| Trails Edge Capital Partners, LP | 31 Dec, 2025 | 0 | 916,313 | 0.00% | $0.00 |
| MARSHALL WACE, LLP | 31 Dec, 2025 | 0 | 3,387,794 | 0.00% | $0.00 |
| Caption Management, LLC | 31 Dec, 2025 | 0 | 767,698 | 0.00% | $0.00 |
| Fisher Asset Management, LLC | 31 Dec, 2025 | 0 | 1,220,635 | 167.40% | $0.00 |
| Soleus Capital Management, L.P. | 31 Dec, 2025 | 0 | 711,983 | 0.00% | $0.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 0 | 308,936 | 19.33% | $0.00 |
| First Turn Management, LLC | 31 Dec, 2025 | 0 | 565,142 | 0.00% | $0.00 |
| BNP Paribas Asset Management Holding S.A. | 31 Dec, 2025 | 0 | 267,389 | 18.83% | $0.00 |